BioSpace News Archive

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will participate in two investor conferences in October.

Cantor Fitzgerald Global Healthcare Conference in New York, NY, on Monday, October 1, 2018 at 2:55 p.m. ET.

The R&D Day will feature presentations by Ira Goldberg, M.D. who will discuss the current treatment landscape and unmet medical need for patients with dyslipidemia and hypertriglyceridemia.

Eiger BioPharmaceuticals, Inc Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced the receipt of written guidance from the FDA, confirming concurrence on a pivotal trial design, including the primary endpoint for D-LIVR, the first-ever, registration study for Hepatitis Delta Virus (HDV) infection.

Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the company will participate in two investor conferences in October.

William Lautman, Managing Partner of Nexus Health Capital, a New York and Dallas-based Healthcare Investment Bank, today announced a one million dollar planned gift in addition to five hundred thousand dollars donated to Smile Train in order to bring forever smiles to children with clefts in Argentina and around the world.

Dr. Bimonte-Nelson will be honored by Arizona’s bioscience and business communities for the diverse and innovative ways that she has inspired students of all ages at the 2018 AZBio Awards on October 3, 2018 at the Phoenix Convention Center.

Pharmaceutical companies share significant concerns over their ability to bring more drugs to market faster due to clinical data challenge

Professor Alessandro Repici, Director of the Digestive Endoscopy Unit of Istituto Clinico Humanitas, will serve as the Principal Investigator.

Several new formulary wins improve TRULANCE 2018 and 2019 coverage status across major U.S. Commercial, Medicare Part D and Managed Medicaid plans.